Skip to main content

Table 3 Odds ratios (women vs men) for stage IV disease by screening status and diagnostic delay

From: Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer

 

Stage IV

Unadjusteda

 

Adjusteda,b

 

OR (95% CI)

p-value

OR (95%)

p-value

Screening

 No

1.23 (0.67–2.16)

0.48

1.04 (0.61–1.77)

0.89

 Yes

6.9 (0.88–53.96)

0.06

7.20 (0.93–55.79)

0.05

 Unknown

3.05 (2.27–4.11)

< 0.0005

4.26 (3.18–5.72)

< 0.0005

Diagnostic delay

  ≤ 3 months

1.07 (0.56–2.08)

0.83

0.95 (0.49–1.85)

0.99

  > 3 months

6.25 (1.57–24.89)

0.009

5.05 (1.18–21.58)

0.03

 Unknown

3.61 (1.19–10.96)

0.02

3.91 (1.13–13.53)

0.03

  1. aWe used generalized estimating equations to estimate the women-to-men odds ratios (ORs) in each stratum of the variables with significant multiplicative interactions
  2. bAdjusted for age, comorbidity, and preoperative radiotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us